| Translational - CNIO

Home | News | Translational

Translational

Infografía proyecto IMPaCT_VUSCan. /underbau. CNIO Translational
30.06.2023
The biggest ever Spanish project to identify cancer risk genes kicks off Currently, only some of those who are at higher risk than normal can know their predisposition to...
Translational
16.06.2023
eClinicalMedicine. The use of genomic sequencing panels to personalise cancer treatment is beneficial in only 5% of the patients in whom they are currently used In recent years, the use of genomic sequencing panels in cancer treatment has become widespread....
Translational
07.03.2023
CNIO researchers propose biomarkers to select breast cancer patients who could benefit from denosumab treatment The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a...
Translational
14.11.2022
Gonçalo Bernardes, an expert in the development of precision medicine oncology drugs, begins his ‘Fundación Jesús Serra’ research stay at CNIO Gonçalo Bernardes, Professor of Biological Chemistry at Cambridge University (UK), has begun his...
Translational
15.06.2022
Nature. New biomarkers unlock potential for more effective treatment of deadly cancers Researchers at the Spanish National Cancer Research Centre (CNIO) and the Cancer Research UK...
Translational
11.04.2022
Nature Medicine. CNIO researchers find a way to increase effectiveness of radiotherapy for brain metastasis A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used...
Translational
09.03.2022
Gut. An international study proposes stool analysis for early detection of pancreatic cancer Pancreatic cancer is not one of the most frequently diagnosed cancers, but it is one of the most...
Translational
17.02.2022
EMBO Molecular Medicine. CNIO researchers design a drug screening platform compatible with patient biopsies to fight metastasis It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate...
Translational
31.01.2022
Scientific Reports. CNIO researchers identify drugs potentially capable of reducing the mortality of COVID-19 Inflammation is a defence mechanism of the body to fight pathogens. However, when it is widespread...

Up